Global Vasculitis Treatment Market Size study & Forecast, and Regional Analysis, 2022-2029

by Drug Class (Biologics, Corticosteroids and immunosuppressants), by Disease Type (Small and medium vessel vasculitis, Large vessel vasculitis), by Distribution Channel (Hospital Pharmacies, Drug stores and retail pharmacies, Online Pharmacies)

Published	Pages	Publisher	Report code
Feb 2023	200	Bizwit Research	ASDR-616026

Published: Feb 2023 - Pages : 200 - Publisher : Bizwit Research - Report code : ASDR-616026

Amneal Pharmaceuticals Inc.
AstraZeneca plc
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Pfizer Inc.
InflaRx N.V
Novartis AG
ChemoCentryx Inc.
AbbVie Inc.
Teva Pharmaceutical Industries Ltd.

Vasculitis Treatment - Global Forecast 2024-2030

This report can be of interest as well:

Vasculitis Treatment - Global Forecast 2024-2030

Published: January, 2024 | Report code: ASDR-653372